These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19593252)

  • 1. Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
    Wade KC; Benjamin DK; Kaufman DA; Ward RM; Smith PB; Jayaraman B; Adamson PC; Gastonguay MR; Barrett JS
    Pediatr Infect Dis J; 2009 Aug; 28(8):717-23. PubMed ID: 19593252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of fluconazole in young infants.
    Wade KC; Wu D; Kaufman DA; Ward RM; Benjamin DK; Sullivan JE; Ramey N; Jayaraman B; Hoppu K; Adamson PC; Gastonguay MR; Barrett JS;
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants.
    Engbers AGJ; Flint RB; Voeller S; Reiss I; Liem KD; Alffenaar JC; Tibboel D; Simons S; Knibbe CAJ; Brüggemann RJ
    Arch Dis Child; 2022 Apr; 107(4):400-406. PubMed ID: 35074829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.
    Watt KM; Benjamin DK; Cheifetz IM; Moorthy G; Wade KC; Smith PB; Brouwer KL; Capparelli EV; Cohen-Wolkowiez M
    Pediatr Infect Dis J; 2012 Oct; 31(10):1042-7. PubMed ID: 22627870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN; Mueller BA
    Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
    Leroux S; Jacqz-Aigrain E; Elie V; Legrand F; Barin-Le Guellec C; Aurich B; Biran V; Dusang B; Goudjil S; Coopman S; Garcia Sanchez R; Zhao W; Manzoni P;
    Br J Clin Pharmacol; 2018 Sep; 84(9):1989-1999. PubMed ID: 29744900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole loading dose pharmacokinetics and safety in infants.
    Piper L; Smith PB; Hornik CP; Cheifetz IM; Barrett JS; Moorthy G; Hope WW; Wade KC; Cohen-Wolkowiez M; Benjamin DK
    Pediatr Infect Dis J; 2011 May; 30(5):375-8. PubMed ID: 21085048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.
    Momper JD; Capparelli EV; Wade KC; Kantak A; Dhanireddy R; Cummings JJ; Nedrelow JH; Hudak ML; Mundakel GT; Natarajan G; Gao J; Laughon M; Smith PB; Benjamin DK
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5539-45. PubMed ID: 27401564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).
    Ratzlaff K; Papich MG; Flammer K
    J Avian Med Surg; 2011 Mar; 25(1):23-31. PubMed ID: 21657184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Study of Prophylactic Fluconazole in Preterm Infants for Prevention of Invasive Candidiasis.
    Kim YK; Lee J; Oh J; Rhee SJ; Shin SH; Yoon SH; Lee S; Kim HS; Yu KS
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
    Cojutti PG; Lugano M; Righi E; Della Rocca G; Bassetti M; Hope W; Pea F
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1449-1459. PubMed ID: 30032414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.
    Wang H; Li D; Jiang Y; Liang J; Yu Q; Kuang L; Huang Y; Qin D; Li P; He J; Xu F; Li X; Wang F; Wei Y; Li X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38850301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants.
    Tanzawa A; Saito J; Shoji K; Kojo Y; Funaki T; Maruyama H; Isayama T; Ito Y; Nakamura H; Yamatani A
    Microbiol Spectr; 2022 Apr; 10(2):e0195221. PubMed ID: 35266811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life.
    Saxén H; Hoppu K; Pohjavuori M
    Clin Pharmacol Ther; 1993 Sep; 54(3):269-77. PubMed ID: 8375121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
    Patel K; Roberts JA; Lipman J; Tett SE; Deldot ME; Kirkpatrick CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children.
    van der Elst KC; Pereboom M; van den Heuvel ER; Kosterink JG; Schölvinck EH; Alffenaar JW
    Clin Infect Dis; 2014 Dec; 59(11):1527-33. PubMed ID: 25148892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.